Literature DB >> 22797448

Clopidogrel efficacy and cigarette smoking status.

Paul A Gurbel1, Thomas D Nolin, Udaya S Tantry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22797448     DOI： 10.1001/jama.2012.5930

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.

Authors:  Gail D Anderson; Lingtak-Neander Chan
Journal:  Clin Pharmacokinet       Date:  2016-11       Impact factor: 6.447

Review 2.  Cigarette smoking and clopidogrel interaction.

Authors:  Kristopher J Swiger; Omair Yousuf; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

3.  Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery disease.

Authors:  Jung Rae Cho; Bhaloo Desai; Michael J Haas; Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Antonio Tello-Montoliu; Elisabetta Ferrante; Luis A Guzman; Theodore A Bass; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2013-12-20       Impact factor: 4.132

4.  Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study.

Authors:  Fabiana Rollini; Francesco Franchi; Jung Rae Cho; Christopher Degroat; Mona Bhatti; Elisabetta Ferrante; Ronakkumar Patel; Andrew Darlington; Antonio Tello-Montoliu; Bhaloo Desai; Joséluis Ferreiro; Ana Muniz-Lozano; Martin M Zenni; Luis A Guzman; Theodore A Bass; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2014-01-07       Impact factor: 4.132

5.  Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial.

Authors:  James F Meschia; Ronald L Walton; Luca P Farrugia; Owen A Ross; Jordan J Elm; Mary Farrant; William J Meurer; Anne S Lindblad; William Barsan; Marilou Ching; Nina Gentile; Michael Ross; Fadi Nahab; J Donald Easton; Anthony S Kim; Karla G Zurita; Brett Cucchiara; S Claiborne Johnston
Journal:  Stroke       Date:  2020-06-17       Impact factor: 10.170

Review 6.  A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users.

Authors:  Ruben L Osnabrugge; Stuart J Head; Felix Zijlstra; Jurriën M ten Berg; Myriam G Hunink; A Pieter Kappetein; A Cecile J W Janssens
Journal:  Genet Med       Date:  2014-06-19       Impact factor: 8.822

7.  Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison.

Authors:  Joshua J Gagne; Katsiaryana Bykov; Niteesh K Choudhry; Timothy J Toomey; John G Connolly; Jerry Avorn
Journal:  BMJ       Date:  2013-09-17

8.  Advances in our understanding of "resistance" to antiplatelet agents for prevention of ischemic stroke.

Authors:  Philip B Gorelick; Muhammad U Farooq
Journal:  Stroke Res Treat       Date:  2013-07-14

9.  Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.

Authors:  Matthias Bossard; Christopher B Granger; Jean-Francois Tanguay; Gilles Montalescot; David P Faxon; Sanjit S Jolly; Petr Widimsky; Kari Niemela; Philippe Gabriel Steg; Madhu K Natarajan; Peggy Gao; Keith A A Fox; Salim Yusuf; Shamir R Mehta
Journal:  J Am Heart Assoc       Date:  2017-11-03       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.